Oralance Pharma Overview

  • Founded
  • 2003
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 4
Employees
  • Latest Deal Type
  • Buyout/​LBO
  • Financing Rounds
  • 4

Oralance Pharma General Information

Description

Developer of a new oral drug delivery system. The company's technology is applied to a wide range of pharmaceuticals in the form of syrups, tablets, powder to dilute, lyophilics, gel, paste forms and aqueous suspensions and is based on an original galenic micro-encapsulation process.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • 24 rue du faubourg
  • 75000 Paris
  • France
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Oralance Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Oralance Pharma‘s full profile, request access.

Request a free trial

Oralance Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Oralance Pharma Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Oralance Pharma‘s full profile, request access.

Request a free trial